Preventive Care in Nursing and Midwifery Journal
Sat, Jan 11, 2025
[Archive]
Volume 8, Issue 4 (3-2019)
PCNM 2019, 8(4): 51-56 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Farnam F. Assisting IUD and DMPA Users with Overcoming their Sexual and Mood Problems. PCNM 2019; 8 (4) :51-56
URL: http://nmcjournal.zums.ac.ir/article-1-619-en.html
URL: http://nmcjournal.zums.ac.ir/article-1-619-en.html
Ph.D in Reproductive Health, Department of Reproductive Health, Tehran University of Medical Sciences, Tehran, Iran , f_farnam@yahoo.com
Abstract: (6252 Views)
Background: Contraceptive side effects have been recognized as the most important reasons accounting for discontinuation of the methods.
Objectives: The present study attempts to identify the probable side effects that negatively affect sexual satisfaction and depression in Intra Uterine Device (IUD) and Depo-Medroxyprogestrone Acetate (DMPA) users.
Methods: 150 IUD users and 150 DMPA users who had started the respective contraceptive method since the past 12-18 months participated in a cross-sectional study conducted in 34 health centers from August 2017 to January 2018, in Tehran, Iran. Index of Sexual Satisfaction and Patient Health Questionnaire were used for assessing sexual satisfaction and depression in the participants, respectively.
Results: Chi-square and independent t-test showed no significant difference between demographic characteristic in the two groups (P>0.05). The linear logistic regression analysis showed that no variables affect sexual satisfaction in IUD users, while depression (P=0.01, B=1.12) and dysmenorrhea (P=0.05, B=2.06) were meaningful factors accounting for sexual satisfaction in DMPA users. Influential factors on depression were dysmenorrhea (P= 0.005, B=0.41) in IUD users, and sexual satisfaction (P= 0.005, B=0.05) and weight gain (P=0.029, B=0.31) in DMPA users. Pearson test showed a significant correlation between sexual satisfaction and depression (P=0.05, Pearson correlation=0.11).
Conclusion: This study helps clinicians to improve sexual satisfaction and mood levels in IUD and DMPA users by manipulating some influential factors. With regard to the correlation between sexual satisfaction and depression, health providers should pay greater attention to these clients’ sexual life when they complain of depression, and vice versa
Objectives: The present study attempts to identify the probable side effects that negatively affect sexual satisfaction and depression in Intra Uterine Device (IUD) and Depo-Medroxyprogestrone Acetate (DMPA) users.
Methods: 150 IUD users and 150 DMPA users who had started the respective contraceptive method since the past 12-18 months participated in a cross-sectional study conducted in 34 health centers from August 2017 to January 2018, in Tehran, Iran. Index of Sexual Satisfaction and Patient Health Questionnaire were used for assessing sexual satisfaction and depression in the participants, respectively.
Results: Chi-square and independent t-test showed no significant difference between demographic characteristic in the two groups (P>0.05). The linear logistic regression analysis showed that no variables affect sexual satisfaction in IUD users, while depression (P=0.01, B=1.12) and dysmenorrhea (P=0.05, B=2.06) were meaningful factors accounting for sexual satisfaction in DMPA users. Influential factors on depression were dysmenorrhea (P= 0.005, B=0.41) in IUD users, and sexual satisfaction (P= 0.005, B=0.05) and weight gain (P=0.029, B=0.31) in DMPA users. Pearson test showed a significant correlation between sexual satisfaction and depression (P=0.05, Pearson correlation=0.11).
Conclusion: This study helps clinicians to improve sexual satisfaction and mood levels in IUD and DMPA users by manipulating some influential factors. With regard to the correlation between sexual satisfaction and depression, health providers should pay greater attention to these clients’ sexual life when they complain of depression, and vice versa
Keywords: copper intra uterine device, depo-medroxyprogesterone acetate, sexual satisfaction, depression, associated factors
Type of Study: Orginal research |
Subject:
Midwifery
Received: 2020/02/5 | Accepted: 2019/03/1 | Published: 2019/03/1
Received: 2020/02/5 | Accepted: 2019/03/1 | Published: 2019/03/1
References
1. Department of Economic and Social Affairs Population Division. Trends in Contraceptive Use Worldwide. United Nations, New York. 2015.
2. World Health Organization, Hopkins J. Family planning: a global handbook for providers: evidence-based guidance developed through worldwide collaboration. 3rd ed. Geneva; 2007.
3. United Nation. Department of Economic and Social Affairs, Population Division (2019). Contraceptive Use by Method 2019: Data Booklet [cited 1 feb 2020]. Available at: URL: https://www.un.org/en/development/desa/population/publications/pdf/family/ContraceptiveUseByMethodDataBooklet2019.pdf
4. Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9(9):2213-23. [crossref]
5. Higgins JA, Davis AR. Contraceptive sex acceptability: a commentary, synopsis and agenda for future research. Contraception. 2014; 90(1): 4-10. [crossref]
6. Ott MA, Shew ML, Ofner S, Tu W, Fortenberry JD. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav. 2008; 37(4): 605-13. []
7. Gupta N, O'Brien R, Jacobsen LJ, et al. Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study. J Pediatr Adol Gynec. 2001; 14(2): 71-6. [crossref]
8. Pasanad SH-M, Farnam F, Damghanian M. The effect of the copper intrauterine device (Cu-IUD) and the injectable depo-medroxyprogesterone acetate (DMPA) use on women’s sexual satisfaction and depression. Nursing Practice Today. 2020; 7(1): 53-60.
9. Hudson WW, Harrison DF, Crosscup PC. A short‐form scale to measure sexual discord in dyadic relationships. J Sex Res. 1981; 17(2): 157-74. [crossref]
10. Kroenke K, Spitzer RL, Williams JB. The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9): 606-13. [crossref]
11. Khamseh ME, Baradaran HR, Javanbakht A, Mirghorbani M, Yadollahi Z, Malek M. Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran. BMC psychiatry. 2011; 11(1): 61. [crossref]
12. Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women’s Well-Being and Sexuality Study. Sex Health. 2008; 5(4): 321-30. [crossref]
13. Smith NK, Jozkowski KN, Sanders SA. Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med. 2014; 11(2): 462-70. [crossref]
14. Saptatangtrakun Y, Wattanayingcharoenchai R, Manonai J, Aimjirakul K. Sexual Function in Women Using DMPA Injection and Copper Intrauterine Device. Thai J Obstetrics & Gynaecol. 2016: 24; 294-301.
15. Civic D, Scholes D, Ichikawa L, et al. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception. 2000; 61(6): 385-90. [crossref]
16. Sanders JN, Smith NK, Higgins JA. The intimate link: a systematic review of highly effective reversible contraception and women’s sexual experience. Clin Obstet Gynecol. 2014; 57(4): 777-89. [crossref]
17. Gagua T, Tkeshelashvili B, Gagua D, Mchedlishvili N. Assessment of anxiety and depression in adolescents with primary dysmenorrhea: a case-control study. J Pediatr Adol Gynec. 2013; 26(6): 350-54 [crossref]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
